Christopher Anzalone

Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC.

Net worth: 309 M $ as of 2026-06-29

56 year

28 connections

Health Technology

Consumer Services

Finance

Profile

Christopher Richard Anzalone is a businessperson who founded Benet Group LLC and Nanotope, Inc. and who has been the head of 5 different companies. Currently, he is President, Chief Executive Officer & Director at Arrowhead Pharmaceuticals, Inc. and Chairman & Chief Executive Officer of Calando Pharmaceuticals, Inc. (a subsidiary of Arrowhead Pharmaceuticals, Inc.). Dr. Anzalone is also on the board of 5 other companies. In his past career Dr. Anzalone was Chief Executive Officer for NanoInk, Inc., Partner at Galway Partners LLC, President, Chief Executive Officer & Director at Nanotope, Inc. and Chief Executive Officer at Benet Group LLC. Christopher Richard Anzalone received a doctorate from the University of California, Los Angeles and an undergraduate degree from Lawrence University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ARROWHEAD PHARMACEUTICALS, INC. 2.69%	2026-01-14	3,792,739 ( 2.69% )	309 M $	2026-06-29

Christopher Anzalone active positions

Companies	Position	Start
ARROWHEAD PHARMACEUTICALS, INC.	Chief Executive Officer	2007-11-30
Ablaris Therapeutics, Inc.	Director/Board Member	-
Tego Biosciences Corp.	Director/Board Member	-
Arrowhead Madison, Inc.	Director/Board Member	-

All active positions of Christopher Anzalone

Former positions of Christopher Anzalone

Companies	Position	End
NanoInk, Inc. NanoInk, Inc. Industrial MachineryProducer Manufacturing Manufactures nanolithography tools and other nanoscale devices	President	2003-12-31
Galway Partners LLC Galway Partners LLC Investment ManagersFinance Acts as an alternative investment manager	Corporate Officer/Principal	2002-12-31
KRONOS BIO, INC.	Director/Board Member	-
VIR BIOTECHNOLOGY, INC.	Director/Board Member	-
Roche Madison, Inc. Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Provides gene transfer technologies to the pharmaceutical industry	Director/Board Member	-

See the detail of Christopher Anzalone's experience

Training of Christopher Anzalone

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Anzalone's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases	Health Technology
NanoInk, Inc. NanoInk, Inc. Industrial MachineryProducer Manufacturing Manufactures nanolithography tools and other nanoscale devices	Producer Manufacturing
Calando Pharmaceuticals, Inc. Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics	Health Technology
Nanotope, Inc. Nanotope, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lawrence University Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roche Madison, Inc. Roche Madison, Inc. Pharmaceuticals: MajorHealth Technology Provides gene transfer technologies to the pharmaceutical industry	Health Technology
Unidym, Inc. Unidym, Inc. Electronic Production EquipmentElectronic Technology Develops and manufactures carbon nanotubes	Electronic Technology
Benet Group LLC Benet Group LLC Financial ConglomeratesFinance Private equity firm	Finance
Galway Partners LLC Galway Partners LLC Investment ManagersFinance Acts as an alternative investment manager	Finance
Ablaris Therapeutics, Inc.
Tego Biosciences Corp.
Arrowhead Madison, Inc.
Vir Biotechnology, Inc. Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases	Health Technology
Kronos Bio, Inc. Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics	Health Technology